กำลังเล่นซ้ำ วันพฤหัสบดีที่ 14 พฤศจิกายน ค.ศ. 2002

14 พฤศจิกายน ค.ศ. 2002 เป็น วันพฤหัสบดี ใต้เครื่องหมายดาวของ เป็นวันที่ 317 ของปี ประธานาธิบดีแห่งสหรัฐอเมริกาคือ George W. Bush

ถ้าคุณเกิดในวันนี้ แสดงว่าคุณอายุ 23 ปี วันเกิดล่าสุดของคุณคือเมื่อ วันศุกร์ที่ 14 พฤศจิกายน ค.ศ. 2025, 206 วันที่ผ่านมา วันเกิดครั้งต่อไปของคุณคือวันที่ วันเสาร์ที่ 14 พฤศจิกายน ค.ศ. 2026 ในอีก 158 วัน คุณมีชีวิตอยู่ได้ 8,607 วัน หรือประมาณ 206,579 ชั่วโมง หรือประมาณ 12,394,759 นาที หรือประมาณ 743,685,540 วินาที

บางคนที่แบ่งปันวันเกิดนี้:

14th of November 2002 News

ข่าวที่ปรากฏบนหน้าแรกของ New York Times เมื่อ 14 พฤศจิกายน ค.ศ. 2002

DRUG PRODUCER SAYS IT MAY MISS 2002 REVENUE GOAL

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Shares of Ligand Pharmaceuticals fall 26 percent after company says it may not meet its 2002 revenue goal; discloses news on Nov 12 when it reported $7 million third-quarter loss (S)

Full Article

GROCERY DISTRIBUTOR SAYS IT IS SUBJECT OF S.E.C. INQUIRY

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Securities and Exchange Commission conducts informal investigation into sales and accounting practices of Fleming Companies, nation's largest grocery distributor; separately, company says it will sell 28 of its California grocery stores to Save Mart Supermarkets for as much as $130 million (S)

Full Article

BOEING ENGINEERS TO VOTE ON 3-YEAR CONTRACT

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Boeing Co engineers represented by Society of Professional Engineering Employees in Aerospace will vote to recommend three-year contract that gives them annual raises of 4 percent and requires them to pay more for some health insurance plans; company anticipates 25 percent drop in deliveries of commercial jets during 2003 (S)

Full Article

HONEYWELL AUTHORIZES $900 MILLION FOR PENSION FUND

Date: 15 November 2002

By Bloomberg News

Bloomberg News

Honeywell International says it might spend $900 million to finance its pension plan and might not have sufficient insurance for asbestos claims; share price declines 8 percent, or $2.09, to $23.16; company will take $1.7 billion charge against equity because of pension plan losses; about $2 billion insurance remaining to pay for asbestos lawsuits involving its former North American Refractories division may not cover settlement costs (S)

Full Article

PATHMARK SHARES PLUNGE AFTER WARNING ON EARNINGS

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Pathmark Stores warns that its fiscal fourth-quarter results will be lower than it forecast; stock price plunges 23 percent (S)

Full Article

CANCER DRUG COMPANY ACQUIRES STEM CELL TECHNOLOGY

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Celgene Corp agrees to pay $45 million in stock to acquire Anthrogenesis Corp and gain its technology for harvesting stem cells that may be used for cancer treatments (S)

Full Article

CLOROX AND P.&G. PLAN JOINT VENTURE FOR GLAD PRODUCTS

Date: 15 November 2002

By Bloomberg News

Bloomberg News

Clorox Co and Procter & Gamble Co will undertake joint venture to develop more products for Glad bags, wraps and containers; P&G will have initial 10 percent ownership in venture and contribute some patents and technology; Clorox will administer joint venture (S)

Full Article

ALLSTATE CUTS PROFIT AFTER ASBESTOS ACCORD

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Allstate Corp settles asbestos claim requiring it to delete $32 million from profit it reported in October; believes its reserves for asbestos litigation are adequate (S)

Full Article

STARBUCKS SAYS EARNINGS ROSE 9.8% IN FOURTH QUARTER

Date: 15 November 2002

By Bloomberg News

Bloomberg News

Starbucks Corp reports 9.8 percent fourth-quarter earnings rise, to $58.5 million; sales gain 25 percent, to $865.2 million (S)

Full Article

JOHNSON & JOHNSON TO BUY DRUG MAKER FOR $110 MILLION

Date: 14 November 2002

By Bloomberg News

Bloomberg News

Johnson & Johnson agrees to purchase OraPharma for about $110 million to increase its share of market for medicines that treat diseases of mouth; OraPharma shareholders will receive $7.41 for each share held, 63 percent premium over its Nov 12 closing price (S)

Full Article